PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Clinical trial NCT02681783 · UNKNOWN

Trial details

NCT number: NCT02681783
Sponsor: Sunnybrook Health Sciences Centre
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy Age Related Macular Degeneration Idiopathic Poplypoidal Choroidal Vasculopathy

Start date: 2018-12-01
Primary completion: 2022-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.